Imaging dopamine transporters with I-123 altropane: Preliminary report of a phase 1 clinical trial.

被引:0
|
作者
Mercier, G
Pourdehnad, M
Alavi, A
Reivich, M
Mozley, D
Fischman, A
Lanser, M
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Boston Life Sci, Boston, MA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
952
引用
收藏
页码:214P / 214P
页数:1
相关论文
共 50 条
  • [21] Dopamine and serotonin transporters in patients with schizophrenia:: An imaging study with [123I]β-CIT
    Laruelle, M
    Abi-Dargham, A
    van Dyck, C
    Gil, R
    D'Souza, DC
    Krystal, J
    Seibyl, J
    Baldwin, R
    Innis, R
    BIOLOGICAL PSYCHIATRY, 2000, 47 (05) : 371 - 379
  • [22] I-123 MIBG imaging and intraoperative localization of metastatic pheochromocytoma - A case report
    Buhl, T
    Mortensen, J
    Kjaer, A
    CLINICAL NUCLEAR MEDICINE, 2002, 27 (03) : 183 - 185
  • [23] SPECT IMAGING OF DOPAMINE-RECEPTORS WITH [I-123] EPIDEPRIDE - CHARACTERIZATION OF UPTAKE IN THE HUMAN BRAIN
    KORNHUBER, J
    BRUCKE, T
    ANGELBERGER, P
    ASENBAUM, S
    PODREKA, I
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1995, 101 (1-3) : 95 - 103
  • [24] Comparison of I-123 and I-131 for whole-body imaging after stimulation by recombinant human thyrotropin - A preliminary report
    Anderson, GS
    Fish, S
    Nakhoda, K
    Zhuang, HM
    Alavi, A
    Mandel, SJ
    CLINICAL NUCLEAR MEDICINE, 2003, 28 (02) : 93 - 96
  • [25] (I-123) IBZM - A POTENTIAL CNS D-2 DOPAMINE RECEPTOR IMAGING AGENT - PRELIMINARY-RESULTS IN MONKEY AND HUMANS
    ALAVI, A
    KUNG, H
    KUNG, MP
    PAN, S
    BILLINGS, J
    KASLIWAL, R
    REIVICH, M
    REILLEY, J
    CEREBRAL VASCULAR DISEASE 7, 1989, 858 : 135 - 136
  • [26] I-123 SCH-23982 IS NOT SUITABLE FOR DOPAMINE-D1 RECEPTOR IMAGING INVIVO IN THE HUMAN BRAIN
    VERHOEFF, NPLG
    BEKIER, A
    BEER, HF
    SCHUBIGER, PA
    FENNEMA, P
    VANROYEN, EA
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (02) : 137 - 144
  • [27] DOPAMINE D2-RECEPTOR IMAGING WITH I-123 IODOBENZAMIDE SPECT IN PATIENTS WITH THE PARKINSONIAN SYNDROME - CLINICAL-SIGNIFICANCE
    VERHOEFF, NPLG
    SPEELMAN, JD
    KUIPER, MA
    VANROYEN, EA
    KAPUCU, O
    BOER, GJ
    JANSSEN, AGM
    WOLTERS, EC
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P207 - P207
  • [28] NONINVASIVE ASSESSMENT OF HUMAN TUMOR HYPOXIA WITH I-123 IODOAZOMYCIN ARABINOSIDE - PRELIMINARY-REPORT OF A CLINICAL-STUDY
    PARLIAMENT, MB
    CHAPMAN, JD
    URTASUN, RC
    MCEWAN, AJ
    GOLBERG, L
    MERCER, JR
    MANNAN, RH
    WIEBE, LI
    BRITISH JOURNAL OF CANCER, 1992, 65 (01) : 90 - 95
  • [29] Reproducibility of SPECT imaging of dopamine transporters with 123I-FPCIT in healthy subjects.
    Tsuchida, T
    Ballinger, J
    Vines, D
    Kim, YJ
    Naruse, A
    Utsunomiya, K
    Lang, AE
    Ichise, M
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 271P - 272P
  • [30] Imaging serotonin and dopamine transporters with dynamic 123I-β-CIT SPECT in mouse brain
    Pitkonen, M.
    Hippelainen, E.
    Raki, M.
    Savolainen, S.
    Andressoo, J.
    Saarma, M.
    Bergstrom, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S413 - S414